XML 24 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Acquisitions
 3 Months Ended
Sep. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Business Combination
2. Acquisitions
Solaris Health
On August 12, 2025, we announced that we, through the Specialty Alliance, have entered into a definitive agreement to acquire Solaris Health, a urology MSO, for a purchase price of approximately $1.9 billion in cash, subject to certain adjustments. In connection with the closing of this transaction, we will issue common units in the Specialty Alliance to certain physicians and management which are estimated to have a grant date fair value of approximately $500 million, a portion of which will be recognized as post-combination expense within acquisition-related cash and share-based compensation costs.
Solaris Health includes more than 750 providers across more than 250 practice locations in 14 states. Solaris Health will become part of The Specialty Alliance, our multi-specialty MSO platform, and their results will be reported within our Pharma segment. Following the closing of this transaction, we will own approximately 75% of The Specialty Alliance. This transaction is subject to the satisfaction of customary closing conditions, including receipt of required physician and regulatory approvals.
We intend to finance the transaction with a combination of cash proceeds from the recent debt financing and cash on hand. See Note 5 for additional information on the debt financing.
Advanced Diabetes Supply Group ("ADS")
On April 1, 2025, we completed the acquisition of ADS for a purchase price of approximately $1.0 billion in cash, subject to certain adjustments.
Transaction and integration costs associated with the ADS acquisition were $3 million for the three months ended September 30, 2025.
GI Alliance ("GIA")
On January 30, 2025, we completed the acquisition of a 73 percent ownership interest in GIA for a purchase price of approximately $2.8 billion in cash, subject to certain adjustments. Beginning on the third anniversary of the closing, we have the ability to exercise a call right to purchase up to 100 percent of the remaining outstanding interests.
Additionally, on May 30, 2025, we, through the Specialty Alliance, completed the acquisition of Urology America for a purchase price of $381 million in cash and equity in the Specialty Alliance, subject to certain adjustments.
Transaction and integration costs associated with the GIA acquisitions were $11 million for the three months ended September 30, 2025.
Integrated Oncology Network ("ION")
On December 2, 2024, we completed the acquisition of ION for a purchase price of $1.1 billion in cash, subject to certain adjustments.
Transaction and integration costs associated with the ION acquisition were $1 million for the three months ended September 30, 2025.
Fair Value of Assets Acquired and Liabilities Assumed
The allocation of the purchase price for the acquisition of Urology America, ADS, GIA, and ION are not yet finalized and are subject to adjustment as we complete the valuation analysis of these acquisitions. The purchase prices are also subject to adjustment based on working capital requirements as set forth in the acquisition agreements.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed as of the acquisition date for Urology America, ADS, GIA, and ION:
(in millions)
Urology America
ADSGIAION
Identifiable intangible assets:
Customer intangibles (1)
$— $472 $— $226 
Trade names (2)
33 28 200 73 
Non-competition agreements (3)
— — 23 — 
Total identifiable intangible assets acquired
33 500 223 299 
Identifiable net assets/(liabilities):
Cash and equivalents
4 14 53 8 
Trade receivables, net
23 101 191 59 
Inventories3 78 21 4 
Prepaid expenses and other3 8 13 5 
Property and equipment, net28 1 75 39 
Other assets
41 377 312 52 
Accounts payable(20)(104)(89)(10)
Current portion of long-term obligations and other short-term borrowings— — (1)(3)
Other accrued liabilities(11)(488)(173)(40)
Long-term obligations, less current portion(6)— (15)(14)
Deferred income taxes and other liabilities(46)(13)(915)(90)
Total identifiable net assets/(liabilities) acquired52 474 (305)309 
Noncontrolling interest(9)— — (121)
Goodwill
338 575 3,090 881 
Total net assets acquired
$381 $1,049 $2,785 $1,069